A Randomized Recruitment Intervention Trial

NCT ID: NCT01911208

Last Updated: 2018-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2017-10-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test a recruitment intervention to increase racial and ethnic diversity in clinical trials. The trial will be conducted in specialty care clinics. In RECRUIT minorities are those underrepresented in clinical trials and include:

* African Americans/ Blacks
* Asians
* Native Hawaiians/Other Pacific Islanders
* Hispanic/Latinos
* Native Americans/Alaskan Natives

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Low minority participation in clinical trials limits our ability to assess and address potential differences in therapeutic responses. To address the problem of low minority recruitment we are initiating a randomized trial of a recruitment intervention (RECRUIT) funded by the National Institute on Minority Health and Health disparities (NIMHD) to increase racial/ethnic diversity in clinical trials.

Our specific approach is directed toward multi-site trials conducted at specialty clinics within academic centers with recruiting venues that include community practices or practices of colleagues in other areas of the academic center. The intervention will focus on approximately 60 specialty clinics. Clinical sites will be randomized to the intervention or control group. The target of the intervention will be the site investigators and clinical trial coordinators.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Recruitment of Minorities

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RECRUIT intervention

Clinical sites will work with the RECRUIT team to enhance and individualize their recruitment methods.

Group Type EXPERIMENTAL

RECRUIT intervention

Intervention Type BEHAVIORAL

Sites randomized to RECRUIT are taught skills to develop a tailored recruitment intervention encompassing continuous quality improvement and patient navigation.

Control

Clinical sites can use which ever recruitment methods they prefer.

Group Type EXPERIMENTAL

Control

Intervention Type BEHAVIORAL

Non-intervention control.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RECRUIT intervention

Sites randomized to RECRUIT are taught skills to develop a tailored recruitment intervention encompassing continuous quality improvement and patient navigation.

Intervention Type BEHAVIORAL

Control

Non-intervention control.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

A parent trial must :

* have a coordinating Center willing to allow their Clinical Sites to participate;
* be studying be studying a condition that requires community or health system physician referral
* be studying an intervention where the recruitment approach cannot be made directly to minority community members
* need to increase recruitment of racially/ethnically diverse participants\* to the trial as demonstrated by current trial progress or historical data from other trials in the same disease;
* be a Phase II or Phase III trial
* be conducted in at least six multiple sites;
* expect each Clinical Site to recruit at least 10 participants;
* be funded by a sponsor (NIH or pharmaceutical company or other) that has a strong commitment to recruiting racially/ethnically diverse subjects;
* be willing to have investigators and coordinators attend a special training meeting (at RECRUIT expense);
* require randomization to intervention or control (could be best medical care or active control or placebo or other type of control);
* provide transportation costs for trial participants who need assistance in getting to trial sites or use some RECRUIT reimbursement for this purpose.

The clinical site must

* be a funded Clinical Site in the parent trial;
* be located in an area where at least 20% of the population within 30 miles in the age group under study in the parent trial are from diverse populations.

Exclusion Criteria

* site does not agree to be randomized;
* investigator or coordinator is under 18 years of age.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

Sponsor Role collaborator

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Barbara Tilley

SPH Faculty - Biostatistics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Barbara C. Tilley, PhD

Role: PRINCIPAL_INVESTIGATOR

The University of Texas Health Science Center, Houston

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Texas Health Science Center School of Public Health

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Tilley BC, Mainous AG 3rd, Amorrortu RP, McKee MD, Smith DW, Li R, DeSantis SM, Vernon SW, Koch G, Ford ME, Diaz V, Alvidrez J; additional RECRUIT Trial Center and Parent Trials' investigators. Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial. Contemp Clin Trials. 2021 Oct;109:106519. doi: 10.1016/j.cct.2021.106519. Epub 2021 Jul 30.

Reference Type DERIVED
PMID: 34333138 (View on PubMed)

DeSantis SM, Li R, Zhang Y, Wang X, Vernon SW, Tilley BC, Koch G. Intent-to-treat analysis of cluster randomized trials when clusters report unidentifiable outcome proportions. Clin Trials. 2020 Dec;17(6):627-636. doi: 10.1177/1740774520936668. Epub 2020 Aug 24.

Reference Type DERIVED
PMID: 32838555 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U24MD006941

Identifier Type: NIH

Identifier Source: secondary_id

View Link

NIMHD006941

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PrEP Affect Regulation Treatment Innovation
NCT04899024 ACTIVE_NOT_RECRUITING NA